Adanikin Abiodun I, Awoleke Jacob O, Olofinbiyi Babatunde A, Adanikin Pipeloluwa O, Ogundare Omobolanle R
Department of Obstetrics and Gynecology, Ekiti State University, Ado-Ekiti, Nigeria.
Department of Family Medicine, Ekiti State University Teaching Hospital, Ado-Ekiti, Nigeria.
Ethiop J Health Sci. 2015 Oct;25(4):305-12. doi: 10.4314/ejhs.v25i4.3.
Anaemia in pregnancy is associated with adverse maternal and fetal outcome. Unfortunately, in developing countries its prevalence has continued to rise. To improve the situation, iron supplement is routinely prescribed during pregnancy. We therefore examine the impact of the intervention as being currently practised in our clinical setting.
In total, 255 prenatal clinic attendees who had more than 8 weeks of prescribed iron supplements were sampled. Data was obtained on their socio-demographic features, haemoglobin concentration at booking, compliance with iron supplements and third trimester haemoglobin value.
Observed iron supplementation compliance rate was 184(72.2%). There was a significant drop in mean haemoglobin (Hb) concentration between the two time points (booking Hb: 32.56±2.99; third trimester Hb: 31.67±3.01; mean diff: 0.89±3.04; t = 4.673; 95% CI= 0.52-1.27; p= <0.001). Anaemia increased from 132(51.8%) to 150(58.8%) by the third trimester. Increase in anaemia occurred in both iron-compliant and non-compliant groups. Non-compliance however had higher odds of predicting anaemia by the third trimester (OR: 1.83; 95% CI: 1.03-3.26; p: 0.04).
Although iron supplementation is still a good intervention in developing countries, it is not sufficient to reduce overall prevalence of anaemia by the third trimester. There is a need to look beyond the approach and reinforce the importance of better feeding practices, food fortification and reduced frequency of pregnancies.
孕期贫血与母婴不良结局相关。遗憾的是,在发展中国家,其患病率持续上升。为改善这种情况,孕期常规开具铁补充剂。因此,我们研究了目前在临床环境中实施的这种干预措施的影响。
总共抽取了255名服用铁补充剂超过8周的产前门诊就诊者。获取了他们的社会人口学特征、建档时的血红蛋白浓度、铁补充剂的依从性以及孕晚期血红蛋白值的数据。
观察到的铁补充剂依从率为184人(72.2%)。两个时间点之间的平均血红蛋白(Hb)浓度有显著下降(建档时Hb:32.56±2.99;孕晚期Hb:31.67±3.01;平均差值:0.89±3.04;t = 4.673;95%置信区间 = 0.52 - 1.27;p = <0.001)。到孕晚期,贫血从132人(51.8%)增加到150人(58.8%)。贫血的增加在铁补充剂依从组和不依从组中均有发生。然而,不依从者在孕晚期发生贫血的几率更高(比值比:1.83;95%置信区间:1.03 - 3.26;p:0.04)。
虽然在发展中国家补充铁剂仍然是一种有效的干预措施,但不足以降低孕晚期贫血的总体患病率。有必要超越这种方法,强化良好喂养习惯、食品强化和减少怀孕频率的重要性。